Medicine

Scientists at PSI have used mechanical stimuli to turn connective tissue cells into stem-cell-like cells and transplanted these into damaged skin tissue. This speeds up the regeneration of the skin and the healing of wounds.

PSI researchers take pictures of cell nuclei using modern high-resolution imaging techniques, employ learning algorithms to comb through these data, and thus can more reliably identify anomalies.

Each cell in the human body contains a cytoskeleton. Contrary to what the name suggests, the cytoskeleton is far more than just a support structure.

The cytoskeleton is a little marvel. Probing it promises to reveal, among other things, new possibilities for cancer therapy.

On 15 August 2023 a patient suffering from oesophageal cancer was treated with proton beam therapy at PSI – for the very first time in Switzerland.

A project that promises to improve the chances of survival for prostate cancer patients has received 2 million Swiss francs in funding.

A two-part upgrade is planned for HIPA from 2025 to 2028. Preparations are already under way.

Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.

Improved method thanks to a molecular trick

From research to production – the new pharmaceutical lab at PSI supplies neighbouring hospitals with novel cancer drugs.

Employing high-resolution X-rays to diagnose breast cancer – PSI researchers nominated for the European Inventor Award.

PSI is involved in the development of a breath test that can be used to diagnose asthma. Imad El Haddad explains why such a test could be extremely useful – especially for children.

The test identifies different virus variants and improves disease prognosis.

This gallery presents five people who have been treated at the PSI's Center for Proton Therapy.

Kantonsspital Baden and the Paul Scherrer Institute PSI have signed a cooperation agreement.

Combining two chemotherapeutic drugs inhibits tumour growth.

In partnership with Roche, PSI scientists are developing new, potentially more efficient catalysts for manufacturing active substances for drug therapies.

25 November 1996: a world first for PSI’s Center for Proton Therapy in treating a cancer patient using the spot-scanning technique.

On 9 November 2021 a lung cancer patient was given proton therapy at the Paul Scherrer Institute PSI for the first time in Switzerland.

PSI researchers identify potential active agent against several unicellular parasites – including the pathogens that cause malaria and toxoplasmosis.